• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻患者肺腺癌的临床病理和分子特征。

Clinicopathologic and molecular characteristics of lung adenocarcinoma arising in young patients.

机构信息

Department of Pathology, Inha University School of Medicine, Incheon, Korea.

出版信息

J Korean Med Sci. 2012 Sep;27(9):1027-36. doi: 10.3346/jkms.2012.27.9.1027. Epub 2012 Aug 22.

DOI:10.3346/jkms.2012.27.9.1027
PMID:22969248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3429819/
Abstract

Lung cancer rarely occurs in young patients. Recent studies have demonstrated that epidemiologic data are closely correlated to some molecular characteristics. We investigated the clinicopathologic characteristics of lung adenocarcinoma in young patients and evaluated immunohistochemically detected epidermal growth factor receptor (EGFR) mutation status and anaplastic lymphoma kinase (ALK) positivity. Among lung adenocarcinoma patients, 31 cases were of the ≤ 40 yr-old group and 261 cases of > 50 yr-old group. Young patients were more likely to be females (67.7% vs 40.2%), and nonsmokers (58.1% vs 45.2%) and more often had high TNM stage (stage IV was 80.6% vs 52.1%) and had a high rate of distant metastasis (51.6% vs 28.0%) compared with older patients. The signet ring cell feature was more common (25.8% vs 11.5%) and lepidic growth pattern was rarely present (3.2% vs 16.5%) in the adenocarcinoma of young patients. There was no significant survival difference between the two age groups. The rate of EGFR mutation status and ALK positivity did not show a statistical difference between two groups. In conclusion, lung adenocarcinoma of young patients demonstrates distinct pathologic features with frequent presence of a signet ring cell feature and rare occurrence of lepidic growth pattern. Further investigation for other genetic abnormalities would be needed.

摘要

肺癌在年轻患者中很少发生。最近的研究表明,流行病学数据与某些分子特征密切相关。我们调查了年轻患者肺腺癌的临床病理特征,并评估了表皮生长因子受体(EGFR)突变状态和间变性淋巴瘤激酶(ALK)阳性的免疫组织化学检测。在肺腺癌患者中,31 例为≤40 岁组,261 例为>50 岁组。年轻患者更可能为女性(67.7%比 40.2%)和不吸烟者(58.1%比 45.2%),且更常处于较高的 TNM 分期(IV 期为 80.6%比 52.1%),远处转移率更高(51.6%比 28.0%)。与老年患者相比,年轻患者的腺癌中更常见印戒细胞特征(25.8%比 11.5%),而贴壁生长模式较少见(3.2%比 16.5%)。两组间的生存差异无统计学意义。两组间 EGFR 突变状态和 ALK 阳性率无统计学差异。总之,年轻患者的肺腺癌具有明显的病理特征,常存在印戒细胞特征,贴壁生长模式罕见。需要进一步研究其他遗传异常。

相似文献

1
Clinicopathologic and molecular characteristics of lung adenocarcinoma arising in young patients.年轻患者肺腺癌的临床病理和分子特征。
J Korean Med Sci. 2012 Sep;27(9):1027-36. doi: 10.3346/jkms.2012.27.9.1027. Epub 2012 Aug 22.
2
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.甲状腺转录因子1(TTF-1)、 napsin A、切除修复交叉互补蛋白1(ERCC1)、间变性淋巴瘤激酶(ALK)及表皮生长因子受体(EGFR)表达在肺腺癌患者小活检预后中的应用——一项来自克罗地亚的单中心回顾性研究
Med Sci Monit. 2017 Jan 27;23:489-497. doi: 10.12659/msm.899378.
3
Comparison of clinical characteristics between patients with ALK-positive and EGFR-positive lung adenocarcinoma.ALK阳性与EGFR阳性肺腺癌患者临床特征的比较。
Respir Med. 2014 Feb;108(2):388-94. doi: 10.1016/j.rmed.2013.11.020. Epub 2013 Dec 10.
4
Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.年轻肺腺癌患者致癌基因改变的独特患病率。
Cancer. 2017 May 15;123(10):1731-1740. doi: 10.1002/cncr.30539. Epub 2017 Feb 8.
5
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.携带EML4-ALK的非小细胞肺癌患者的临床特征及预后
J Clin Oncol. 2009 Sep 10;27(26):4247-53. doi: 10.1200/JCO.2009.22.6993. Epub 2009 Aug 10.
6
Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.突变谱与新的国际肺癌研究协会/美国胸科学会/欧洲呼吸学会分类为肺腺癌提供了额外的预后信息:一项对125例巴西患者的研究。
Oncology. 2015;89(3):175-86. doi: 10.1159/000376552. Epub 2015 Apr 1.
7
Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.中国表皮生长因子受体(EGFR)野生型肺腺癌患者中HER-2突变的流行病学研究。
BMC Cancer. 2016 Oct 28;16(1):828. doi: 10.1186/s12885-016-2875-z.
8
A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype.基于驱动癌基因突变的ALK重排肺腺癌组织形态学特征的综合比较分析:上皮-间质转化标志物的表达比其他基因型更频繁。
PLoS One. 2013 Oct 23;8(10):e76999. doi: 10.1371/journal.pone.0076999. eCollection 2013.
9
Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells.ALK 阳性肺腺癌的细胞形态学特征:砂粒体和印戒细胞。
Cancer Cytopathol. 2015 Mar;123(3):162-70. doi: 10.1002/cncy.21507. Epub 2014 Dec 29.
10
[To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].[评估肺腺癌患者肿瘤细胞经气腔播散的临床病理特征及预后]
Zhonghua Bing Li Xue Za Zhi. 2017 May 8;46(5):303-308. doi: 10.3760/cma.j.issn.0529-5807.2017.05.004.

引用本文的文献

1
Lung cancer in young individuals; risk factors and epidemiology.年轻个体中的肺癌;危险因素与流行病学
J Thorac Dis. 2025 Mar 31;17(3):1746-1754. doi: 10.21037/jtd-2024-1950. Epub 2025 Mar 21.
2
Combined model integrating deep learning, radiomics, and clinical data to classify lung nodules at chest CT.联合深度学习、影像组学和临床数据的模型用于在胸部 CT 上对肺结节进行分类。
Radiol Med. 2024 Jan;129(1):56-69. doi: 10.1007/s11547-023-01730-6. Epub 2023 Nov 16.
3
Clinicopathological features and prognostic significance of pulmonary adenocarcinoma with signet ring cell components: meta-analysis and SEER analysis.

本文引用的文献

1
Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer.非小细胞肺癌中的肿瘤内异质性和 EGFR 状态的化疗诱导变化。
Cancer Chemother Pharmacol. 2012 Feb;69(2):289-99. doi: 10.1007/s00280-011-1791-9. Epub 2011 Dec 1.
2
Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma.肺腺癌中 EGFR 突变的异质性分布极为罕见。
J Clin Oncol. 2011 Aug 1;29(22):2972-7. doi: 10.1200/JCO.2010.33.3906. Epub 2011 Jul 5.
3
Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
具有印戒细胞成分的肺腺癌的临床病理特征及预后意义:荟萃分析和 SEER 分析。
Clin Exp Med. 2023 Dec;23(8):4341-4354. doi: 10.1007/s10238-023-01200-3. Epub 2023 Oct 1.
4
High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis.长链非编码RNA HEIH的高表达有助于非小细胞肺癌的诊断并预示预后不良。
Cancer Manag Res. 2022 Feb 9;14:503-514. doi: 10.2147/CMAR.S320965. eCollection 2022.
5
Chemotherapy in combination with pembrolizumab and antiangiogenesis in young patients with advanced primary pulmonary mucinous adenocarcinoma: Two case reports.化疗联合帕博利珠单抗和抗血管生成治疗年轻晚期原发性肺黏液性腺癌患者:两例报告。
Sci Prog. 2021 Oct;104(4):368504211061971. doi: 10.1177/00368504211061971.
6
[Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma].[中国年轻肺腺癌患者的基因图谱]
Zhongguo Fei Ai Za Zhi. 2020 Apr 20;23(4):239-246. doi: 10.3779/j.issn.1009-3419.2020.101.17.
7
Distinctive lung cancer incidence trends among men and women attributable to the period effect in Shanghai: An analysis spanning 42 years.上海地区因时期效应导致的男性和女性肺癌发病率独特趋势:一项跨越42年的分析
Cancer Med. 2020 Apr;9(8):2930-2939. doi: 10.1002/cam4.2917. Epub 2020 Feb 19.
8
Molecular features of lung adenocarcinoma in young patients.年轻患者肺腺癌的分子特征。
BMC Cancer. 2019 Aug 6;19(1):777. doi: 10.1186/s12885-019-5978-5.
9
EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases.表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)联合脑部放疗与单纯EGFR-TKI治疗表皮生长因子受体(EGFR)突变的非小细胞肺癌(NSCLC)脑转移患者的疗效比较
Transl Lung Cancer Res. 2019 Jun;8(3):268-279. doi: 10.21037/tlcr.2019.06.12.
10
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients.年轻和老年肺腺癌患者中LKB1通路的表达谱及微小RNA调控
Biomed Rep. 2018 Sep;9(3):198-205. doi: 10.3892/br.2018.1122. Epub 2018 Jul 2.
免疫组织化学检测非小细胞肺癌间变性淋巴瘤激酶重排:与荧光原位杂交的相关性。
J Thorac Oncol. 2011 Mar;6(3):466-72. doi: 10.1097/JTO.0b013e31820b82e8.
4
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类。
J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.
5
Cancer statistics in Korea: incidence, mortality and survival in 2006-2007.韩国癌症统计数据:2006-2007 年的发病率、死亡率和生存率。
J Korean Med Sci. 2010 Aug;25(8):1113-21. doi: 10.3346/jkms.2010.25.8.1113. Epub 2010 Jul 21.
6
Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.使用针对两种主要形式的突变型 EGFR 的抗体,通过免疫组织化学方法评估肺腺癌中的 EGFR 突变状态。
J Mol Diagn. 2010 Mar;12(2):169-76. doi: 10.2353/jmoldx.2010.090140. Epub 2010 Jan 21.
7
Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.年轻人非小细胞肺癌(NSCLC)的显著特征:监测、流行病学和最终结果(SEER)分析。
J Thorac Oncol. 2010 Jan;5(1):23-8. doi: 10.1097/JTO.0b013e3181c41e8d.
8
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.独特的临床病理特征是西方人群中ALK重排肺腺癌的特点。
Clin Cancer Res. 2009 Aug 15;15(16):5216-23. doi: 10.1158/1078-0432.CCR-09-0802. Epub 2009 Aug 11.
9
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.携带EML4-ALK的非小细胞肺癌患者的临床特征及预后
J Clin Oncol. 2009 Sep 10;27(26):4247-53. doi: 10.1200/JCO.2009.22.6993. Epub 2009 Aug 10.
10
Bronchogenic carcinoma in patients under 50 years old.50岁以下患者的支气管源性癌
Clin Transl Oncol. 2009 May;11(5):322-5. doi: 10.1007/s12094-009-0361-7.